This media is in the public domain (free of copyright restrictions). You can copy, modify, and distribute this work without contacting the Smithsonian. For more information, visit the Smithsonian's ...

Don’t Let the Sun Go Up on Me”, “La Más Dulce,” and “Chapa 1000” claimed the top postproduction and development prizes at ...

Retail investors are showing signs of waning confidence in the U.S. stock market's ability to rebound, with market data and analysts' observations both indicating an ebb in their enthusiasm about ...

As part of the 22nd Marrakech International Film Festival (held from November 28 to December 6), the eighth edition of the ...

Vanda Pharmaceuticals stands at a pivotal point, leveraging strong Fanapt growth and a robust late-stage pipeline for future expansion. VNDA's aggressive investment in commercial infrastructure has ...

The FDA has declined to approve Vanda Pharma's tradipitant for delayed gastric emptying (gastroparesis), prompting a furious response from the company. In a statement, the company says the FDA's ...

UK group Cycle Pharma has made an unsolicited takeover bid to buy Vanda Pharma of the US, which is already fending off an overture from Future Pak. The $8-per-share offer values Nasdaq-listed Vanda at ...

Overview: Vanda Pharmaceuticals Inc. is a biopharmaceutical company that develops and commercializes therapies for high unmet medical needs globally, with a market cap of approximately $303.76 million ...

Shares of Vanda Pharmaceuticals rose after a study evaluating its treatment to prevent side effects from weight-loss drug Wegovy met its primary endpoint. The stock climbed 18%, to $5.20, late Tuesday ...

A pair of entrepreneurial brothers who lost their bid to build a hotel in a massive four-storey commercial building next to ...

DISCLAIMER: The views and opinions expressed in this column are solely those of the author and do not necessarily reflect the official policy or position of ...